½ÃÀ庸°í¼­
»óǰÄÚµå
1595286

Æä¼­¸® ½ÃÀå : À¯Çü, Á¦Ç°, ¿ëµµ ¹× ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Pessary Market by Type (Space-Occupying Pessaries, Support Pessaries), Product (Donut, Gellhorn, Ring), Application, End-use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Æä¼­¸® ½ÃÀåÀº 2023³â¿¡ 2¾ï 6,335¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 2¾ï 8,773¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.74%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5¾ï 487¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

Æä¼­¸® ½ÃÀåÀº ÇコÄÉ¾î »ê¾÷¿¡ ÇʼöÀûÀÎ ½ÃÀåÀ¸·Î, ÁÖ·Î °ñ¹Ý ³» Àå±â¸¦ ÁöÁöÇϵµ·Ï ¼³°èµÈ ÀÇ·á±â±â·Î Á¤ÀǵǸç, ÀϹÝÀûÀ¸·Î °ñ¹Ý Àå±â Å»Ãâ ¹× ½ºÆ®·¹½º¼º ¿ä½Ç±Ý°ú °°Àº »óŸ¦ °ü¸®Çϱâ À§ÇØ »ç¿ëµË´Ï´Ù. Æä¼­¸®ÀÇ Çʿ伺Àº °í·ÉÈ­µÈ ¿©¼º Áý´Ü¿¡¼­ ÀÌ·¯ÇÑ Áõ»óÀÌ Á¡Á¡ ´õ ³Î¸® ÆÛÁö°í Àֱ⠶§¹®¿¡ ¼ö¼ú ¿ÜÀûÀÎ °³ÀÔÀ¸·Î Æä¼­¸®ÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. Æä¼­¸®´Â ÁÖ·Î ºÎÀΰú Áø·á¿¡ Àû¿ëµÇ¸ç, Áõ»óÀ» ¿ÏÈ­ÇÏ°í »îÀÇ ÁúÀ» °³¼±ÇÏ¸ç °æ¿ì¿¡ µû¶ó¼­´Â ¿Ü°úÀû °³ÀÔÀÇ Çʿ伺À» ´ÊÃß±â À§ÇØ ÀÇ·á Àü¹®°¡°¡ »ç¿ëÇÕ´Ï´Ù. ÃÖÁ¾ ¿ëµµ¿¡´Â º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ºÎÀΰú Àü¹® Ŭ¸®´Ð µîÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº °ñ¹Ý Àå±â Å»ÃâÁõÀÇ ¹ßº´·ü Áõ°¡, ȯÀÚÀÇ Æí¾ÈÇÔ°ú È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â ±â±â ¼³°èÀÇ ±â¼ú ¹ßÀü, ºñ¼ö¼úÀû °ü¸® ¹æ¹ý¿¡ ´ëÇÑ È¯ÀÚ ÀÎ½Ä Áõ°¡ µîÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡°¡ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù ºñÁî´Ï½º ±âȸ·Î´Â ȯÀÚÀÇ Æí¾ÈÇÔ°ú ȯ°æÀû Áö¼Ó°¡´É¼ºÀ» ³ôÀÏ ¼ö ÀÖ´Â ¸ÂÃãÇü »ýºÐÇØ¼º Æä¼­¸®ÀÇ °³¹ß, ¹ÌÃæÁ· ÀÇ·á ¼ö¿ä°¡ ÀÖ´Â ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ ÀÎÁöµµ È®´ë µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª Æä¼­¸® Âø¿ë¿¡ ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·, ȯÀÚÀÇ ÄÄÇöóÀ̾𽺠¹®Á¦, ÀϺΠÁö¿ª¿¡¼­´Â ¹®È­Àû ³«ÀÎÀ¸·Î ÀÎÇÑ °ú¼Ò½Å°í µîÀÇ ¹®Á¦°¡ ÀÖ½À´Ï´Ù. ±ÔÁ¦ À庮°ú »óȯ ¹®Á¦´Â ½ÃÀå È®´ë¸¦ ´õ¿í ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀº Ç×±Õ Æ¯¼ºÀ» ÅëÇÕÇÑ Ã·´Ü ¼ÒÀçÀÇ Æä¼­¸® °³¹ß°ú ¸ð´ÏÅ͸µ ¹× Çǵå¹éÀ» À§ÇÑ µðÁöÅÐ Çコ ÅëÇÕ¿¡ ÃÊÁ¡À» ¸ÂÃß¾î¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, ºÒÈ®½Ç¼ºÀ» ÇØ°áÇϰí ÀÓ»ó °á°ú¸¦ °³¼±Çϱâ À§ÇØ »ç¿ëÀÇ Àå±âÀûÀÎ ¿µÇâÀ» Á¶»çÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº °æÀïÀûÀÌÁö¸¸ ¼ºÀåÇϰí ÀÖÀ¸¸ç, ȯÀÚ Áß½ÉÀÇ Çõ½Å°ú Á¦Ç° Á¢±Ù¼º ¹× »ç¿ë¼ºÀ» Çâ»ó½ÃŰ´Â Àü·«Àû Á¦ÈÞ¿¡ ÁßÁ¡À» µÎ¾î ÁøÈ­ÇÏ´Â ÇコÄɾî ȯ°æ¿¡¼­ Áö¼ÓÀûÀÎ °ü·Ã¼ºÀ» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 2¾ï 6,335¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 2¾ï 8,773¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 5¾ï 487¸¸ ´Þ·¯
CAGR(%) 9.74%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Æä¼­¸® ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Æä»ç¸® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °ñ¹ÝÀå±âÅ»ÃâÁõ ±ÞÁõ
    • °Ç°­¿¡ ´ëÇÑ Àνİú ÇÔ²² Áõ°¡ÇÏ´Â °í·É ¿©¼º Àα¸ Áõ°¡
    • È£¸£¸ó ±³¶õÀ¸·Î À̾îÁö´Â »ýȰ½À°ü º¯È­ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °ñ¹ÝÀå±âÅ»ÃâÁõ Áø´Ü ºÒ·®
  • ½ÃÀå ±âȸ
    • º¸´Ù À¯¿¬Çϰí ÀÚ±ØÀÌ ÀûÀº Æä¼­¸® °³¹ßÀ» À§ÇÑ ¿¬±¸ °³¹ß Áõ°¡
    • ÀÇ·á¿¡ ´ëÇÑ ³ôÀº ÁöÃâ°ú À¯¸®ÇÑ »óȯ Á¤Ã¥
    • ºñħ½ÀÀû Ä¡·áÀÇ ºü¸¥ ÁøÈ­
  • ½ÃÀå °úÁ¦
    • Æä¼­¸® »ç¿ëÀ¸·Î ÀÎÇÑ ÇÕº´Áõ

Portre's Five Forces: Æä¼­¸® ½ÃÀå °ø·«À» À§ÇÑ Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Æä¼­¸® ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

PESTLE ºÐ¼®

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Æä¼­¸® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Æä»ç¸® ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

Æä¼­¸® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Æä¼­¸® ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Æä¼­¸® ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ Æä¼­¸® ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

Æä»ç¸® ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

    Á¦6Àå Æä¼­¸® ½ÃÀå : À¯Çüº°

    • Space-Occupying Pessaries
    • Support Pessaries

    Á¦7Àå Æä¼­¸® ½ÃÀå : Á¦Ç°º°

    • Donut
    • Gellhorn
    • Ring

    Á¦8Àå Æä¼­¸® ½ÃÀå : ¿ëµµº°

    • °æµµ °ñ¹Ý Àå±âÅ»
    • ÁßÁõ °ñ¹Ý Àå±âÅ»
    • º¹¾Ð¼º ¿ä½Ç±Ý

    Á¦9Àå Æä¼­¸® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • Ŭ¸®´Ð
    • º´¿ø

    Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Æä¼­¸® ½ÃÀå

    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
    • ¹Ì±¹

    Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Æä¼­¸® ½ÃÀå

    • È£ÁÖ
    • Áß±¹
    • Àεµ
    • Àεµ³×½Ã¾Æ
    • ÀϺ»
    • ¸»·¹À̽þÆ
    • Çʸ®ÇÉ
    • ½Ì°¡Æ÷¸£
    • Çѱ¹
    • ´ë¸¸
    • ű¹
    • º£Æ®³²

    Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Æä¼­¸® ½ÃÀå

    • µ§¸¶Å©
    • ÀÌÁýÆ®
    • Çɶõµå
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • À̽º¶ó¿¤
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ³ªÀÌÁö¸®¾Æ
    • ³ë¸£¿þÀÌ
    • Æú¶õµå
    • īŸ¸£
    • ·¯½Ã¾Æ
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ½ºÆäÀÎ
    • ½º¿þµ§
    • ½ºÀ§½º
    • ÅÍŰ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ¿µ±¹

    Á¦13Àå °æÀï ±¸µµ

    • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
    • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
    • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Àü·« ºÐ¼®°ú Á¦¾È

    ±â¾÷ ¸®½ºÆ®

    • Artisan Medical
    • Bioteque America Inc.
    • Bliss GVS Pharma Ltd.
    • Bray Group Ltd.
    • CooperSurgical, Inc.
    • Digitimer Ltd.
    • Dr. Arabin GmbH & Co. KG
    • Gyneas Laboratories by Novomed Group
    • Integra LifeSciences Corporation
    • Marina Medical Inc.
    • medesign I.C. GmbH
    • MedGyn Products, Inc.
    • Mediplus Ltd.
    • Panpac Medical Corporation
    • Personal Medical Corp.
    LSH

    The Pessary Market was valued at USD 263.35 million in 2023, expected to reach USD 287.73 million in 2024, and is projected to grow at a CAGR of 9.74%, to USD 504.87 million by 2030.

    The pessary market is integral to the healthcare industry, primarily defined as a medical device designed to support pelvic organs and is commonly used in managing conditions such as pelvic organ prolapse and stress urinary incontinence. The necessity of pessaries arises due to the increasing prevalence of these conditions among aging female populations, making them an essential non-surgical intervention. They are predominantly applied in gynecological practices and utilized by healthcare professionals to provide symptom relief, improve quality of life, and in some cases, delay the need for surgical intervention. The end-use scope includes hospitals, ambulatory surgical centers, and specialized gynecology clinics. Market growth is being driven by factors such as the rising incidence of pelvic organ prolapse, technological advancements in device design improving patient comfort and efficacy, and increasing patient awareness about non-surgical management options. Additionally, a growing elderly demographic globally is propelling demand. Latest opportunities include the development of customizable and biodegradable pessaries, which can enhance patient comfort and environmental sustainability, as well as expanding awareness in emerging markets with unmet medical needs. However, market growth encounters challenges such as the lack of skilled professionals for fitting pessaries, patient compliance issues, and cultural stigmatization in certain regions leading to underreporting. Regulatory hurdles and reimbursement issues can further impede market expansion. Innovation should focus on developing pessaries with advanced materials incorporating antimicrobial properties, and digital health integration for monitoring and feedback, which can significantly enhance user experience and compliance. Research should also explore the long-term effects of pessary use to address uncertainties and improve clinical outcomes. The market is competitive yet poised for growth, with a strong emphasis on patient-centered innovations and strategic collaborations to advance product accessibility and usability, ensuring sustained relevance in the evolving healthcare landscape.

    KEY MARKET STATISTICS
    Base Year [2023] USD 263.35 million
    Estimated Year [2024] USD 287.73 million
    Forecast Year [2030] USD 504.87 million
    CAGR (%) 9.74%

    Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pessary Market

    The Pessary Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

    • Market Drivers
      • Rapidly increasing prevalence of pelvic organ prolapse
      • Growing geriatric women population coupled with awareness about health
      • Increasing lifestyle changes leading to hormonal disturbances
    • Market Restraints
      • Poor diagnosis of the disorder
    • Market Opportunities
      • Rising R&D to develop more flexible and irritation-free pessaries
      • High expenditure on healthcare coupled with favorable reimbursement policies
      • Rapid evolution of noninvasive treatment
    • Market Challenges
      • Complications caused by use of pessaries

    Porter's Five Forces: A Strategic Tool for Navigating the Pessary Market

    Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pessary Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

    PESTLE Analysis: Navigating External Influences in the Pessary Market

    External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pessary Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

    Market Share Analysis: Understanding the Competitive Landscape in the Pessary Market

    A detailed market share analysis in the Pessary Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

    FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pessary Market

    The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pessary Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

    Strategy Analysis & Recommendation: Charting a Path to Success in the Pessary Market

    A strategic analysis of the Pessary Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

    Key Company Profiles

    The report delves into recent significant developments in the Pessary Market, highlighting leading vendors and their innovative profiles. These include Artisan Medical, Bioteque America Inc., Bliss GVS Pharma Ltd., Bray Group Ltd., CooperSurgical, Inc., Digitimer Ltd., Dr. Arabin GmbH & Co. KG, Gyneas Laboratories by Novomed Group, Integra LifeSciences Corporation, Marina Medical Inc., medesign I.C. GmbH, MedGyn Products, Inc., Mediplus Ltd., Panpac Medical Corporation, and Personal Medical Corp..

    Market Segmentation & Coverage

    This research report categorizes the Pessary Market to forecast the revenues and analyze trends in each of the following sub-markets:

    • Based on Type, market is studied across Space-Occupying Pessaries and Support Pessaries.
    • Based on Product, market is studied across Donut, Gellhorn, and Ring.
    • Based on Application, market is studied across Mild Pelvic Organ Prolapse, Severe Pelvic Organ Prolapse, and Stress Urinary Incontinence.
    • Based on End-use, market is studied across Ambulatory Surgical Centres, Clinics, and Hospitals.
    • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

    The report offers a comprehensive analysis of the market, covering key focus areas:

    1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

    2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

    3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

    4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

    5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

    The report also answers critical questions to aid stakeholders in making informed decisions:

    1. What is the current market size, and what is the forecasted growth?

    2. Which products, segments, and regions offer the best investment opportunities?

    3. What are the key technology trends and regulatory influences shaping the market?

    4. How do leading vendors rank in terms of market share and competitive positioning?

    5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

    Table of Contents

    1. Preface

    • 1.1. Objectives of the Study
    • 1.2. Market Segmentation & Coverage
    • 1.3. Years Considered for the Study
    • 1.4. Currency & Pricing
    • 1.5. Language
    • 1.6. Stakeholders

    2. Research Methodology

    • 2.1. Define: Research Objective
    • 2.2. Determine: Research Design
    • 2.3. Prepare: Research Instrument
    • 2.4. Collect: Data Source
    • 2.5. Analyze: Data Interpretation
    • 2.6. Formulate: Data Verification
    • 2.7. Publish: Research Report
    • 2.8. Repeat: Report Update

    3. Executive Summary

    4. Market Overview

    5. Market Insights

    • 5.1. Market Dynamics
      • 5.1.1. Drivers
        • 5.1.1.1. Rapidly increasing prevalence of pelvic organ prolapse
        • 5.1.1.2. Growing geriatric women population coupled with awareness about health
        • 5.1.1.3. Increasing lifestyle changes leading to hormonal disturbances
      • 5.1.2. Restraints
        • 5.1.2.1. Poor diagnosis of the disorder
      • 5.1.3. Opportunities
        • 5.1.3.1. Rising R&D to develop more flexible and irritation-free pessaries
        • 5.1.3.2. High expenditure on healthcare coupled with favorable reimbursement policies
        • 5.1.3.3. Rapid evolution of noninvasive treatment
      • 5.1.4. Challenges
        • 5.1.4.1. Complications caused by use of pessaries
    • 5.2. Market Segmentation Analysis
    • 5.3. Porter's Five Forces Analysis
      • 5.3.1. Threat of New Entrants
      • 5.3.2. Threat of Substitutes
      • 5.3.3. Bargaining Power of Customers
      • 5.3.4. Bargaining Power of Suppliers
      • 5.3.5. Industry Rivalry
    • 5.4. PESTLE Analysis
      • 5.4.1. Political
      • 5.4.2. Economic
      • 5.4.3. Social
      • 5.4.4. Technological
      • 5.4.5. Legal
      • 5.4.6. Environmental

    6. Pessary Market, by Type

    • 6.1. Introduction
    • 6.2. Space-Occupying Pessaries
    • 6.3. Support Pessaries

    7. Pessary Market, by Product

    • 7.1. Introduction
    • 7.2. Donut
    • 7.3. Gellhorn
    • 7.4. Ring

    8. Pessary Market, by Application

    • 8.1. Introduction
    • 8.2. Mild Pelvic Organ Prolapse
    • 8.3. Severe Pelvic Organ Prolapse
    • 8.4. Stress Urinary Incontinence

    9. Pessary Market, by End-use

    • 9.1. Introduction
    • 9.2. Ambulatory Surgical Centres
    • 9.3. Clinics
    • 9.4. Hospitals

    10. Americas Pessary Market

    • 10.1. Introduction
    • 10.2. Argentina
    • 10.3. Brazil
    • 10.4. Canada
    • 10.5. Mexico
    • 10.6. United States

    11. Asia-Pacific Pessary Market

    • 11.1. Introduction
    • 11.2. Australia
    • 11.3. China
    • 11.4. India
    • 11.5. Indonesia
    • 11.6. Japan
    • 11.7. Malaysia
    • 11.8. Philippines
    • 11.9. Singapore
    • 11.10. South Korea
    • 11.11. Taiwan
    • 11.12. Thailand
    • 11.13. Vietnam

    12. Europe, Middle East & Africa Pessary Market

    • 12.1. Introduction
    • 12.2. Denmark
    • 12.3. Egypt
    • 12.4. Finland
    • 12.5. France
    • 12.6. Germany
    • 12.7. Israel
    • 12.8. Italy
    • 12.9. Netherlands
    • 12.10. Nigeria
    • 12.11. Norway
    • 12.12. Poland
    • 12.13. Qatar
    • 12.14. Russia
    • 12.15. Saudi Arabia
    • 12.16. South Africa
    • 12.17. Spain
    • 12.18. Sweden
    • 12.19. Switzerland
    • 12.20. Turkey
    • 12.21. United Arab Emirates
    • 12.22. United Kingdom

    13. Competitive Landscape

    • 13.1. Market Share Analysis, 2023
    • 13.2. FPNV Positioning Matrix, 2023
    • 13.3. Competitive Scenario Analysis
    • 13.4. Strategy Analysis & Recommendation

    Companies Mentioned

    • 1. Artisan Medical
    • 2. Bioteque America Inc.
    • 3. Bliss GVS Pharma Ltd.
    • 4. Bray Group Ltd.
    • 5. CooperSurgical, Inc.
    • 6. Digitimer Ltd.
    • 7. Dr. Arabin GmbH & Co. KG
    • 8. Gyneas Laboratories by Novomed Group
    • 9. Integra LifeSciences Corporation
    • 10. Marina Medical Inc.
    • 11. medesign I.C. GmbH
    • 12. MedGyn Products, Inc.
    • 13. Mediplus Ltd.
    • 14. Panpac Medical Corporation
    • 15. Personal Medical Corp.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦